Biography

Hunter Haines advises entrepreneurs, investors, and emerging growth companies across a wide range of industries, including fintech, biotechnology, pharmaceutical, life sciences, consumer goods, and financial services. 

As a shareholder in SR NEXT, Shulman Rogers’ startup and emerging growth practice, Hunter counsels clients on public and private offerings, venture capital transactions, securities compliance, corporate governance, executive and employee compensation, commercial contracts, business planning, and exit strategies. His active M&A practice means he can advise clients at every stage of the business lifecycle, from formation through exit. 

Clients appreciate Hunter’s care for their broader business objectives. He comes to every engagement without preconceived assumptions, takes the time to understand each client’s specific needs and goals, and brings that understanding into everything he does. 

As one client put it: ‘Since our company is headquartered in London, it was imperative that we understood all of the legalities of doing business in the U.S., and Hunter made us feel confident that we did.

Recognition

  • Best Lawyers: Ones to Watch in America, Potomac, MD, Corporate Law; Mergers and Acquisitions Law, 2024-2027
  • Maryland Super Lawyers, “Rising Stars,” 2026-2027

Professional & Community Affiliations

  • American Bar Association, Member
  • Maryland Bar Association, Member
  • Pi Kappa Alpha – Lambda Omega, Alumni Advisory Board
  • University of Maryland School of Law, Business Law Society Alumni Mentor

News & Insights

1

Results

  • $25.0 million Series B Preferred Stock financing for New York-based real estate technology company
  • $9.0 million Series A Preferred Stock financing for Maryland-based technology company
  • $5.0 million Series Seed Preferred Stock financing for Maryland-based biotech company
  • $5.0 million Series AA Preferred Stock financing for Maryland-based biotech company
  • $4.0 million Simple Agreement for Future Equity financing for an entertainment technology company
  • $4.5 million Series Seed Preferred Stock Financing for U.K.-based fintech company
  • $3.0 million Series Seed Preferred Stock Financing for Virginia-based fintech company
  • $2.5 million Preferred Unit financing for Texas-based entertainment company
  • $2.5 million Convertible Note financing for a Maryland Benefit Corporation
  • $2.0 million Series Seed Preferred Stock financing for Maryland-based biotech company
  • $2.0 million Common Stock Financing for a New York-based biotechnology company
  • $1.5 million Simple Agreement for Future Equity for New York-based real estate technology company
  • $1.0 million Common Stock Financing for a New York-based biotechnology company
  • $2.5 million Convertible Note financing for a Maryland Benefit Corporation
  • $1.070 million Crowdfund financing for New York-based urban development company
  • $1.0 million Simple Agreement for Future Equity for U.K.-based Y-Combinator Alumni
  • $900,000 Simple Agreement for Future Equity for U.S.-based technology company
  • $850,000 Convertible Note financing for Maryland-based technology company
  • $750,000 Simple Agreement for Future Equity for Pennsylvania-based technology company
  • $500,000 Convertible Note financing for Maryland-based consumer health company
  • $500,000 Simple Agreement for Future Equity financing for Virginia-based government contracting company
  • $500,000 Simple Agreement for Future Equity financing for Washington, DC-based consumer goods company
  • $500,000 Simple Agreement for Future Equity financing for California-based health technology company
  • $250,000 Common Stock Financing for Maryland-based consumer goods company
  • $250,000 Convertible Note financing for Maryland-based retail company
  • $250,000 Common Stock Financing for a New York-based biotechnology company
  • Represented issuer of a $250,000 convertible note under the Maryland Momentum Fund, formed and administered by the University System of Maryland (“USM”)
  • Represented issuer of a $100,000 convertible note under the Maryland Momentum Fund, formed and administered by USM
  • Represented issuer of a $200,000 convertible note under the Builder Fund, formed and administered by Maryland’s Technology Development Corporation (“TEDCO”)
  • Represented issuer of a $100,000 convertible note under the Builder Fund, formed and administered by TEDCO
  • $25.0 million Series B Preferred Stock financing Investment for Ohio-based venture capital fund
  • $2.0 million Series A-2 Preferred Stock financing Investment for Virginia area syndicated fund
  • Numerous <$1M Convertible Note and Simple Agreement for Future Equity investments across various industries
  • Deal team of $292.5 million sell-side acquisition of biotechnology company
  • $35 million buy-side acquisition of a minority interest in global consumer goods company
  • $10 million sell-side acquihire of technology company
  • $4.5 million sell-side acquisition of global lobbying firm
  • $1 million sell-side acquisition of biotechnology company